Here's A Fast Strategy To Make It With CAPNS1

It should be noted, that the age limit at which patients are classified as young is not uniform. Some groups take 40 years as the limit, while others take the age of 50. Recently, young patients have also been divided into 3 groups [18, 19, 20?and?21]. Piso et al. [ 8] compared these young patients with a median age of 37 years to a reference group with a median age of 75 years. In his patient population, the ��young patients�� accounted for only 6% (38 of 643 patients). The percentage in the literature varied between 5% and 15% [ 5, 12, 13?and?14]. In our study, the percentage of patients who had gastric cancer at a young age (see more [13, 14?and?22]. This development is also found in our analysis for, both, the reference group and the younger patients. We found 57% of the cancers in the cardia and body in the young patients, with 53% in a similar area in the reference group. This international Talazoparib cost trend is therefore confirmed in both groups. It is noteworthy, that nearly all patients had symptoms prior to the diagnosis that led them to consult a doctor. Only 2% of the younger patients had no symptoms at all. However, compared with 7% in the older reference group, this difference is clear, but not significant. Even if apparently ��harmless�� symptoms in the form of B-symptoms predominate in, both, the young patients and in the reference group, they should be taken seriously and not trivialized in any patients, but particularly those under 50, so that diagnostic investigations can be initiated promptly if there is a slightest suspicion. With the Laur��n classification, the initial outlook for curative CAPNS1 treatment is rather poor because of the histological differentiation in the under-50-year old patients, in whom a diffuse form of the cancer was found in 86% of the cases. In the reference group, the percentage was 49%. This difference is significant with p